SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Widimsky Petr) ;pers:(Kristensen Steen Dalby)"

Search: WFRF:(Widimsky Petr) > Kristensen Steen Dalby

  • Result 1-10 of 13
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Bhatt, Deepak L., et al. (author)
  • Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
  • 2019
  • In: Clinical Cardiology. - : Wiley. - 0160-9289 .- 1932-8737. ; 42:5, s. 498-505
  • Journal article (peer-reviewed)abstract
    • In the setting of prior myocardial infarction, the oral antiplatelet ticagrelor added to aspirin reduced the risk of recurrent ischemic events, especially, in those with diabetes mellitus. Patients with stable coronary disease and diabetes are also at elevated risk and might benefit from dual antiplatelet therapy. The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS, NCT01991795) is a Phase 3b randomized, double-blinded, placebo-controlled trial of ticagrelor vs placebo, on top of low dose aspirin. Patients >= 50 years with type 2 diabetes receiving anti-diabetic medications for at least 6 months with stable coronary artery disease as determined by a history of previous percutaneous coronary intervention, bypass grafting, or angiographic stenosis of >= 50% of at least one coronary artery were enrolled. Patients with known prior myocardial infarction (MI) or stroke were excluded. The primary efficacy endpoint is a composite of cardiovascular death, myocardial infarction, or stroke. The primary safety endpoint is Thrombolysis in Myocardial Infarction major bleeding. A total of 19 220 patients worldwide have been randomized and at least 1385 adjudicated primary efficacy endpoint events are expected to be available for analysis, with an expected average follow-up of 40 months (maximum 58 months). Most of the exposure is on a 60 mg twice daily dose, as the dose was lowered from 90 mg twice daily partway into the study. The results may revise the boundaries of efficacy for dual antiplatelet therapy and whether it has a role outside acute coronary syndromes, prior myocardial infarction, or percutaneous coronary intervention.
  •  
2.
  •  
3.
  • Graham, Ian, et al. (author)
  • European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
  • 2007
  • In: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. - : Oxford University Press (OUP). - 1741-8267. ; 14 Suppl 2
  • Journal article (peer-reviewed)abstract
    • Other experts who contributed to parts of the guidelines: Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG): Alec Vahanian (Chairperson), John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jose Luis Zamorano Document reviewers: Irene Hellemans (CPG Review Co-ordinator), Attila Altiner, Enzo Bonora, Paul N. Durrington, Robert Fagard, Simona Giampaoli, Harry Hemingway, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J. Manolis, Kristina Orth-Gomer, Terje Pedersen, Mike Rayner, Lars Ryden, Mario Sammut, Neil Schneiderman, Anton F. Stalenhoef, Lale Tokgözoglu, Olov Wiklund, Antonis Zampelas
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 13
Type of publication
journal article (13)
Type of content
peer-reviewed (13)
Author/Editor
Widimsky, Petr (13)
Zamorano, Jose Luis (12)
Dean, Veronica (12)
Sechtem, Udo (12)
Funck-Brentano, Chri ... (12)
Vahanian, Alec (12)
show more...
Tendera, Michal (11)
Filippatos, Gerasimo ... (11)
De Caterina, Raffael ... (11)
Dickstein, Kenneth (11)
Silber, Sigmund (11)
McGregor, Keith (11)
Camm, John (10)
Priori, Silvia G (7)
Fagard, Robert (6)
Blomström-Lundqvist, ... (5)
Auricchio, Angelo (5)
De Backer, Guy (5)
Cifkova, Renata (5)
Ruilope, Luis (5)
Linde, Cecilia (4)
Drexler, Helmut (4)
Gasparini, Maurizio (4)
Vardas, Panos E (4)
Blanc, Jean-Jacques (4)
Oto, Ali (4)
Brignole, Michele (4)
Cleland, John (4)
Sutton, Richard (4)
Mancia, Giuseppe (4)
Le Heuzey, Jean-Yves (4)
Daubert, Jean-Claude (4)
Nilsson, Peter M (3)
Laurent, Stephane (3)
Huber, Kurt (3)
Lip, Gregory Y H (3)
Lindholm, Lars H (3)
Reiner, Zeljko (3)
Viigimaa, Margus (3)
Redon, Josep (3)
Narkiewicz, Krzyszto ... (3)
Grassi, Guido (3)
Kjeldsen, Sverre E. (3)
Schmieder, Roland E. (3)
Hoes, Arno (3)
Dalby Kristensen, St ... (3)
Dominiczak, Anna (3)
Zanchetti, Alberto (3)
Rynkiewicz, Andrzej (3)
show less...
University
Uppsala University (7)
University of Gothenburg (4)
Umeå University (3)
Karolinska Institutet (2)
Lund University (1)
Linnaeus University (1)
Language
English (10)
Italian (1)
Polish (1)
Portuguese (1)
Research subject (UKÄ/SCB)
Medical and Health Sciences (3)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view